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Nitric oxide (NO) is produced by a variety of human 
and animal cells and is involved in a broad array of 
physiological and pathophysiological processes. It 
can cause vasodilation, serve as a neurotransmitter, 
and have anti-neoplastic, anti-microbial, and anti-
proliferative effects. 
In this study, we have demonstrated that fibroblasts 
derived from human skin spontaneously produce NO 
and that this production can be enhanced by stimu-
lating the cells with interferon-y and lipopolysaccha-
ride. The production of NO by human dermal fibro-
blasts can be blocked by N G -monomethyl-L-arginine 
(L-NMMA). The inhibitory effect ofL-NMMA on NO 
production was restored by addition of L-arginine 
but not D-arginine. By measuring the rate of conver-
sion of [14C]L-arginine to [14C]L-citrulline, we show 
that unstimulated cells expressed only Ca2 + -depen-
dent NO synthase (NOS) activity (1.36 ± 0.57 pmol/ 
mg/min; n = 4) whereas stimulated cells expressed 
N itric oxide (NO) , originally identified as a blood vessel-relaxing facto r derived from endothelial cells (Palmer el ai, 1987, 1988), has been shown to perform a variety of physiological and pathophys-iological ac tivities, includin g vasodi lation (Hum-
phreys et ai, 1991 ; Benyo el ai, 1991; Kovach el ai, 1992), 
anti-microbial (l-libbs ct ai, 1988) and anti-tumor (Stuelu' and 
Nathan , 1989) ac tivities, immunoregulation (Schneemann et ai, 
1993; Green and Nacy, 1993) , and activities in which it fun ctions as 
a neurotransmitte r (Snyder and Bredt, 1992). The biosynthesis o f 
NO is mediated by NO synthases (NOS), {l-nicotinamide adenine 
din ucleotide phosphate (reduced form)-depend ent enzym es that 
catalyze the oxidation of one of the guanidino nitrogen atom s of 
L-a rginine w ith m o lecular oxygen to form N O and L-citrulline 
(Kwon el ai, 1990; Leone el ai, 1991). T hree isoforms of N OS have 
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both Ca2+ -dependent (2.60 ± 0.54 pmol/mg/min; n = 
4) and -independent (1.59 ± 0.14 pmol/mg/min; n = 4) 
NOS activities. With reverse transcription polymer-
ase chain reaction (RT-PCR), the 422-bp RT-PCR 
product for human endothelial constitutive NOS and 
the 462-bp RT -PCR product for human hepatocyte 
inducible NOS were detected in proportion to the 
amount of rnRNA-related RT-cDNA added to the 
reaction mixture. Further evidence by immunocyto-
chemistry demonstrated that human dermal fibro-
blasts express both constitutive and inducible NOS 
proteins. These data collectively suggest that in ad-
dition to macrophages and other inflammatory cells, 
nitric oxide production by dermal fibroblasts could 
be important during the inflammatory stages of 
wound healing and possibly also in the later stages of 
proliferation and tissue remodeling after skin injury 
in humans. Key luol,ds: lIitric oxide sy"tllase/fibl'ol,la.sts/ 
illte'jeJ'oll y/RT-PCR.] I,west Del'matoI106:419-427, 1996 
been distinguished by cloning their genomic and comple m entary 
DNA in severa l mammalian species, including humans (Bredt cf aI, 
1991; Geller el ai, 1993 ; Marsden el ai, 1992; N akane et ai, 1993; 
Xie et ai, 1992). Activities of two of these isoforms are dependent 
on elevated intracellular Ca2 + and exogenous calmodulin and are 
constitutively expressed (cNOS) . One (endothelial cNOS) appears 
to be res tl'icted to endothelial cells, w hile another is expressed in 
ne uron s (n e ural cNOS) of the central and peripheral nervous 
system and in skeletal muscles (Nakane et ai, 1993) . The third 
isofon11 , inducible NOS (iNOS), is independe n t of e leva ted in t ra-
cellular Ca2 + and possesses its own calmodulin as a tightly bound 
subunit (Cho e/ ai, 1992). T hi s isoforll1 is not expressed under 
normal conditio ns but can be induced in m any types of cell s by 
inflammatory cytokines and bacterial lipopolysaccharide (LPS). 
In human s, as in other mammals (Nathan, 1992), m any types of 
cells have been show n to synthesize N O and express NOS (Nussler 
and Billiar, 1993; Moncada e( ai , 1991; T'lylor- Robinson ('I ai, 
1994). The amount of N O produced by human cell s is mu ch lower 
than tha t b y I'odent cells, however, and there is some contro -
versy over whether hum an monocytes/macrophages produce NO 
(Denis , 1994). Unde r norm al conditions, fibrobl as ts are respo nsibl e 
for tissu e integrity and extracellular m atrix m eta bo lism by prod uc-
ing structural (e .g., coll agens) and functiona l (e.g., coll agenase) 
proteins. Tn damaged tissue, fibrob las ts active ly migrate towards the 
wound site, proliferate, and produ ce more extraceLlular m atrix 
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proteins to facilitate wound healing. Activated fibroblasts in injured 
tissues also produce cytokines such as interl eukin-1 (di Giovine and 
Duff, 1990), interleukin-6 (Willis et ai, 1994), interferon-f3 (IFN-f3) 
and IFN-a (Austyn and Wood, 1993), which furthe r augment the 
inflammatory response of the tissue. Rodent fibroblasts have been 
shown to produce NO upon stimulation with cytokines and LPS 
Oorens et ai, 1992), suggesting that NO produced by fibroblasts 
may play a role in regulating the process of inflammation and 
wound healing, possibly throngh its vasodilator and anti-prolifera-
tive effects (Jorens et ai, 1992). 
Although prodnction of NO by rodent fibroblasts has been 
well-studied, it is not known whether human fIbroblasts express 
NOS or produce NO. In this report, we provide evidence that 
human fibroblasts, in addition to the prodnction of extrace llular 
m atrix proteins, express NOS and synthesize NO, suggesting that 
they may participate' in regulating tbe inflammatory and healing 
process of wounds and scar tissue remodeling . 
MATEIUALS AND METHODS 
CeU Culture Human de111u l fibro blasts were isolated from punch biop-
sies of normal human skin by the standard explant procedure described 
previously (Tredget et aI, 1993). T he cells were cultured in Dulbecco's 
modified Eagle Medilll11 (DMEM; arginine concentration 400 iJ-M; G ibco-
BRL, Grand Island, NY) supplemented with 10% fetal bovine se rum, 10 
ml/l of Antibiotic-Antimycotic (100 X; Gibco-BRL), 20 111M of N-2-
hydroxyeth ylpiperazine-N'-2-e thanesulfonic acid (HE PES) and 3 .7 gil of 
NaHC03 (Sigma Chemical Co ., St. Louis, MO). The cell s were incubated 
at 37°C in an atmosphere of 5% CO2 in air with 95% relative humidity. 
After Passage 4 following the explant, the resulting cell population consisted 
of more than 98'% fibroblasts as assessed by morphological crite ria, typical 
aging profile, growth characteristi cs, and uniformly positive T hy-1 immu-
nostaining (monoclonal antibody against human Thy-1; p rovided by Dr. J . 
Fabre, University o f London (London, U .K.) M cKenzie apd Fabre, 1981 ) . 
Cell straulS from six different individual punch biopsies (uniJ"\iure d skin from 
post-bU111 hypertrophic scar patients; Ghahary el aI, 1992) were used in tlus 
study. All experiments were carri ed out with cell culturcs at Passages 5 to 9. 
Spectrophotomctric Estimation of NO Produced by Human Der-
mal F ibroblasts To measure lutrite production by human de rmal fibro-
blasts, confluent cells in 75_cm 2 tissue culture flasks were trypsulized, 
washed, and resuspended in supplemented DMEM (10% fetal b ovine 
serum; Hyclone Laboratories , Logan, UT) . The cells were coun ted u sing a 
Coul ter Counter (Coulter ElectrOlucs, Inc., Hialeah , FL) and seede d Ulto 
24-well tissue culture plates (Coming Incorporated, Corning, NY) at a 
densiry of 3-5 X 105 cells/well . After incubation for 12 h , the cell s in 
q uadrupli cate wells of 24-well plates were treated with differe nt concen-
trations of human recombinant IFN-y (hrlFN-y; H offinann-La Roche Inc., 
Nutley , NJ), LPS (from Pseudolllollas aemg ;lIosa, serorype 10; Sigma) or a 
combination of both. After incubation at 37°C for differe nt perio ds oftimc , 
lutrite was detc1111ined in the cell-free supernatant b y a spectrophotometri c 
method based on the Griess reaction (Green et aI, 1990). The absorbe ncy at 
550 nm was measured using a microplate reader (Model EAR 400AT; 
SLT-Labinstruments, Gr6dig, Austria) . The nitrite concen tration was cal-
culated from a N aN02 (Sigma) standard curve, corrected for tlle cell 
number, and expressed as nanomoles per 106 cells per 96 h . Background 
levels of ,utrite were determined Ul ce ll-free DMEM with or without the 
additives and were subtracted from the total amount of nitrite formed. The 
detection lunit for nitri te was 1 nmol / ml. For positive controls, J774A.l 
cells, a mouse monocyte/macrophage cell line from American Type Culwre 
Collection, were stimulated with 50 U / m! murine recombinant tumor 
necrosis factor- a (mrTNF-a) plus 10 iJ-g/ ml LPS, and prOduction of NO 
was determined in parallel (Fujihara et aI, 1994). 
Effect ofNG-monomethyl-L-, L-, or D-Arginine on NO Production 
of Human Dermal Fibroblasts To deternune the effect of N G-mono-
methyl-L-arginine (L-NMMA), a competitive inhibitor of NOS, on the 
nitrite production of human dermal fihroblasts, the cells in quadruplica te 
wells of24-well plates were treated with 200 U / ml hrIFN-'Y, 40 JLghnl LPS 
and different concentrations of L-NMMA (acetate salt; Calbiochem , La 
Joll a. CA) for 96 h. The ce ll-free supernatants were collected and analyzed 
for nitrite. To test the e ffect of L- or D-arginine on res toring lutrite 
production by human dermal fibroblasts inlubited by L-Ntv1MA, the ce ll s in 
quadruplicate wells of 24-w ell plates were treated with hrlFN-y, LPS, 250 
JLM ofL-N MMA, and different concentrations o f L- or D-argilune for 96 h . 
The cell-free culture media with or without the addi tives were also assessed 
for background NO fomlation, wluch was subtracted frorP the total. 
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Detection of Ca2+ -Dependent and -Indepcndcnt NOS Activities 
T he Ca2+ -dependent and -independen t NOS activities U1 the cytosol of 
human dermal fibroblasts were determined by measuring the conversion of 
[' 4C lL-arginine to C"C)L-citrulline as described previously (Knowles ei aI, 
1990). The protein content of the ce ll lysates was determined by the 
Bradford dye-bulding proccdure (Bio-Rad. Richmond, CAl using bovine 
serum albunun as a standard. T he Ca2+ -dependcnt NOS activit)' was 
defined as the ethyleneglycol-bis(!3-aminoethyl ethe r)-N. N ,N' ,N ' ,-ter-
raace ti c acid (EGTA}-inlubitable conversion ofL-IV- ' ·'C)arginine to L-[U-
' ·'C l citrulline by the cell lysates. The Ca2+ -indep~nden t N OS activity wa 
d etermined fro m the difference between the L-NMM A-inhibitab le and 
L-NMMA-EGTA-inhibitable activities measured using the conversion of 
the radioactive L-arginine to L-citrulline . For the Ca2+ -dependent NOS 
positive control, rat brains were washed with phosphate-buffered saline 
(PBS), homogelu zed, and assessed fo r NOS activ ities. For the Ca2+_ 
independent N OS-positive contro l, J 774A. 1 ce ll s were stullul ated with 50 
U /mlmrT NF-a and 10 JLg/ml LPS for 18 h and the cytosol was analyzed 
fo r NOS activity in parallel with the cytosol fro m human dermal fi broblasts. 
Detection of mRNAs for cNOS and iNOS in Human Dermal 
Fibroblasts Using Reversc Transcriptasc Polymerasc Chaiu Reac-
tiOll Total RNA was iso lated /iom stimulated and con tro l cells using tlle 
guanid inium isothiocyanate/CsCI procedure of C hirgwin et al (:\ 979) . Five 
micrograms of the iso lated RNA were run on a 1°;', agarose gel conrail1.ing 
1 JLg/ml ethidium bromide to confirm that there was no degradation for the 
RNA. First-strand cDNA (R T -cDNA) was made from total RNA by using 
Superscript RNase H - reverse transcriptase (Superscript RT Il ; Gibco-
BRL) and Oligo (dT), 2_ IB Pri mer (Gibco-BR.L) as primers, using a conven-
tional procedure (Reiling el al. 1994) . 
The polymerase chain reaction (PCR) was carried out in an automatic 
DNA thermal cyclcr (Model T R 96; Tyler Research Instrument Corpora-
tion , Edmonton, Canada) . The fo llowing gene- specific primers were u ed 
to amplifY the desired cDN A: cNOS sense (5' -GTG ATG GCG AAG CGA 
GTG AAG-3 ' ) and cNOS antisense (5'-CCG AGC CCG AAC ACA CAG 
AAC-3'), which correspond to nucleotides 39 - 59 and 440-460 of the 
human umbilical vein endothelial cell cN OS cDNA. respectively; iNOS 
sense (5'-TCC GAG GCA AA C AGC ACA TTC A-3 ' ) and iNOS antisense 
(S'-GGG TTG GGG GTG TGG TGA TGT-3'), which correspond to 
nucleotides 2263- 2284 and 2704-2724 of human hepatocyte iN OS eDNA. 
r espectively. T he primers were syn thesized in the Nucle ic Acid R esearch 
Cente r, University of Alberta. T he reaction mixture contained reaction 
buffer with 2.5 mM MgC I2 , 100 JLM of each of the dNTPs, 0.5 JLM sense 
and anti- sense primers, 2.5 units Taq DNA polym erase (Perkin- Elmer) . and 
diffe rent concentrations of R T -cDNA in a final volume of 50 JLI. T he PCR 
conditions were 30 s of denaturing at 95 °C, 60 s of annealing at 59°C , and 
90 s of ex tension at 73°C for 35 cycles. The amp li fied products were 
ana lyzed on a 1 'Yo agarose (Bio-Rad) gel containing 1 JLg/ml ethidiwlI 
bromide. T he size of the PCR products w ere determined by calcula ting the 
base pai rs between the sense 'Illd anti-sense primers complementary to 
corresponding human endothelial cN OS and hepatocyte iNOS cDNA 
sequ ences and indicated by the lOO-bp D NA molecular weight marker 
(Gibco-BRL). For positive contro ls, the plasmid cDNAs specific for human 
endothelial cNOS and hepatocyte iNOS were used as templates in PCR. 
For negative contro ls, total cellular RNA from human dermal fib roblasts 
witl, out reverse transcription was used as templates in PCR. 
Detection of cNOS and iNOS Protcins in Human Dermal Fibro-
blasts Using Immunocytochcmistry A mo use peroxidase anti-perox-
idase (Sigma) immunostaining procedure was used to detect cNOS and 
iNOS in human dermal fibrob lasts. For cNOS immunostaining, treated 
(IFN-y and LPS for 24 h) or untrc:1ted fibrobh,sts (2.5 X 10") on glas 
nl.i croscope slides were incubated fo r 12 h at 37°C in a humidified chamber 
containing 5% CO2 in air. T he cells were washed with PBS and fixed Ul 4% 
paraforma.!dehydc in PBS for 18 h at 4°C. T he endogeno us peroxidase was 
inactivated by incubating the cells with 50% methanol in Milli-Q H 20 
containing 0.16 iJ-M H 2 0 2 (Fisher Scientifi c Co .. Fair Lawn , NJ) at room 
tcmperature for 45 min. After washulg and permeablizing the cells at room 
temperature for 30 min with 0.05% polyo:l.)'ctllylcne sorbi ta n (Tween 20; 
Fisher) in PBS, nonspec ific binding was blocked w ith 10% nornla.! goat 
se rum at room temperature for 45 min. T he cell s were then incuhated widl 
m onoclonal :1ntibody against human endothelial cNOS (10 JLg/ ml ; Trans-
duction Laboratories. Lexington. KY) for 18 h at 4°C . T he slides were 
washed with PBS and then incubated with 1:100 dilution of btidging 
antibody (goat anti-mouse IgG; Sigma) at room temperature for 45 min. 
After waslung with PBS five times, the slides were treated with peroxidase 
anti-peroxidase complex (Sigma), incubated with substrate solu tion (5 
iJ-g/ml of3,3 ' -dianunobenzidine in 100 mM T ris bulle r, pH 7.2 , containing 
1 JLl / ml of 30% H 2 0 2) at room tcmperature for 10-30 min , and lightly 
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Figu.re 1. Spectrophotometric detection of NO production by 
human dermal fibroblasts. Confluent cells in 24-well plates were treated 
with hrlFN-y and D'S either individually or in combination. Nitrite in the 
cell-free supernatants was measured using the procedures desc ribed in 
Materials ami Me/fwds. A ) Synergistic efFect of IFN-,), and LPS on NO 
production by human fibrob lasts. T he cells were treated w ith PBS (contro l) . 
hrlFN-yalone. LPS alone, or hrlFN-y plus LPS for 96 h . B) Time course of 
NO production by human dermal fibroblasts . The cells were treated with 
hrfFN- y plus LPS (-.-) or incubated in media containing PBS (-e-) . 
Data for all panels represent the mean obtained from three separate 
experiments. £r,.,.r bars. SEM. ' Significant dilference between IFN-y plus 
LPS-treated cells and the other groups. 
countersta ined with Harris ' modified hematoxylin (Fisher). In negative 
controls, the prinlary antibody "vns replaced \v ith noninl111un e nonnal 
mouse IgG. For iN OS immunostaining, fibroblasts on slides were treated 
with IFN-y and LPS for 24 h and stained using the same procedure as for 
cNOS except for that a monoclonal anti body against mouse macrophage 
iNOS (10 /-tg/ ml in PBS containing 0.2% bovine serum albumin; Trans-
duction Laboratories) was used as the primary antibody. To examine NOS 
protein expression by fIbroblast-like cells in dermal tissue, 5-/-tm paraffin 
sections prepared fro m normal skin biopsies were stained with cNOS and 
iNOS antibodies using the above procedure. After immunostaining, the 
slides were examined and microphotographs were taken using a Nikon 
OPTIPHOT-2 microscope equipped with a FX-35DX camera (Nikon 
Optical. Tokyo, Japan). 
RESULTS 
Hu.man Dermal Fibroblasts Spontaneously Produce NO, 
Which Is Increased by IFN-y and LPS Human dermal fibro-
blasts were stimulated with hrlFN-y and LPS alone and in combi-
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Figure 2. Effect ofL-NMMA, L-, or D-arginine on NO production 
by fibroblasts. A) Dose-dependent inhibition of NO production of hum at;' 
fibrob lasts by .l-NMMA. T he IFN-y/ LPS-stimu lated and -unstimulated 
cell s wcre treated with different conccntrations of L-NMMA for 96 h. 
Nitrite in the supernatants were measured with the Griess reaction. B) 
Dose-dcpcndenr restoration of NO production by human fibrob lasts by 
L-argininc. T he IFN-y/LPS-sti lllulated cells were treated with 250 /-tM of 
L-NMMA and different concentrations ofL- (0 ) or D-arginine (.) for 96 
h. Data for both p" nels represent thc mean obta ined from d,rec separate 
experiments. £ 11'01' "aI's. SEM. ' Significant difFerence between L-NMMA-
treated and control cells for stimulated (.) and unstimulated (0 ) cell s or 
between L- (0) or D-"rgilline (.) - treated and control cells. 
nation. With out an y stimulation. the fIbroblasts produced a small 
amount of NO. N e ither IFN-y nor LPS alone signifi.cantly stimu-
late d tbe production of NO, h owever, addition of IFN-y and LPS 
together did (Fig 1A). Human dermal fibroblasts showed dose-
dependent responses to hrIFN-y and LPS, as d e termine d by the 
spectrophotol11etric assay (data not shown) . The combination of 
200 V / ml ofhrIFN- y and 40 f-lg/m l ofLPS induced maximum NO 
production b y th e cells, and th ese con centrations were, therefore, 
use d in aU subseque nt exp e rime nts. 
Figure 1B shows that NO production b y IFN-y/LPS-trea te d 
cells is time d e p e ndent. As shown in this fIg ure . the NO production 
is markedly high er in treated cells at any give n time. The dynamic 
c hange of nitrite in the m e d.ia with time refl ects a b alan ce bet""een 
NO production of the cells and d egradation of nitrite. The contin-
ual in cr eases during the first 4 d a re due to higher rate of NO 
synth esis resulting in accumulatio n of nitrite in conditione d m e dia. 
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Table I. Nitrite Production by Sthnulated and 
Unstimulated Human Dermal Fibroblasts 
and J774A.l Cells 
Fibroblasts 
Stimulated 
Unstimulated 
J774A.l cells 
Stimulated 
Unstimulated 
Nitrite" 
(nmol/ lO" ce ll s/96 h ::': SEM) 
23.43 ::': 2.78" 
12.46 :!: 1 .96 
297.02 :!: 27.90' 
9.64 :!: 2.74 
II Measured using the spectrophotometric procedure based on Grie ss reaction as 
described in Maten'a/s ali(I A4l'f/ lClds. 
/, Signifi cantly higher than ul1stimu la[Cd controls (p = 0.005; n = 8 ; t tcst). 
r Significa ntly higher than unstimulated controls (p < 0.00 1; n = 8 ; t test). 
The decreases found afte rwards are due to reduced NO synth esis of 
the cells after long p eriod of in cubation in the same m edia. 
To de termine NO production by diffe rent strains o f l"Hunan 
dermal fibrob lasts, cells derived from six individua.1 s were c ulture d 
in 24-well plates and stimulated w ith hrlFN-1' and LPS. All stra ins 
of human derm al fibrobla sts tested produced NO and five o ut of six 
strains pro duced significantly higher levels of NO with s timulation 
(data not shown) . As a positive control , the pwduction of NO b y 
the mouse m onocyte/m acrophage cell lin e J774A.l cells was 
examined usin g the Griess reaction . Without stimul a tion , J774A .1 
cells produced NO at a level similar to hU\11at1 derma l fibroblasts. 
When the cells were trea ted with mrTNF-a and LPS. however , 
they produced mu ch higher levels o f NO than hun,an dermal 
fibroblasts (Table I) . 
NO Production by Human Dermal Fibroblasts Is Blocked 
by the Competitive NOS Inhibitor L-NMMA L-NMMA 
inhibited NO production by the cells in a d ose-depend e nt mann e r 
(Fig 2A). This inhibition was n o t due to cytotox icicy since L-
NMMA had no e ffect on the viability of the cells as d etermin ed b y 
the trypan blu e dye excl usion test (data not shown) and its effect 
could b e re versed b y L-arginin e but not b y D-arginine (Fig 2B). 
T he control gro ups in Fig 2B were stimulated with IFN- 1' and LPS 
without L-NMMA. 
Human Dermal Fibroblasts Express Both Ca2 + -Dependent 
and -Independent NOS Activities Table II shows the Ca2 + _ 
dependent and -independe nt NOS ac tivi ties !Tom eytosolic extrac-
tion of rat brain , m rTNF-a/LPS- treated and untreated J774A .1 
. cells and hrlFN-I'/LPS- stimulated and unstimulated huma n dermal 
fibroblasts as measured b y the citrulline assay. R at b rain and 
activatedJ774A.1 cell s were used as positive con trol s foe dete rmin-
ing Ca 2-'--dependent and -independent NOS ac ti vi ties, beca use 
Table II. Ca2+ -Dependent and -Ind~pendel1£ NOS 
Activities in Human Dermal Fibroblasts. J774A.l Cells . 
and Rat Brain 
Fibroblasts 
Stimulated (n = 4) 
Unstimulated (n = 4) 
J774A.l ce lls 
Stimulated (n = 4) 
Unstimulated (n = 4) 
I~at brain (n = 4) 
NOS Activities" 
(1'11101/ mg/min) 
Ca2 + -Dependent 
2.60 ::': 0.54 
1.36 ::': 0.57 
9.67 ::': 2.52 
2.27 ::': 0.83 
2.86 ::': 0.29 
Ca2 + -[ndependent 
1.59 ::': 0 .14 
0 .06 ::': 0 .44 
19.(15 ::': 3.96 
N .D." 
N.D. 
" Determined using the radio 'active citrullin e assay as described i ll NIl/feria/s fIIU' 
Nlcl l/Olls and expressed as picolliolc of L-iHgininc converted by NOS pcr rnilli g ran1 of 
protein in the ce ll lysatcs per min. 
I, N.D ., not dc[cctablc. 
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Figure 3. Expression of mRNAs for cNOS and iNOS in hU11lan 
fibroblasts . RT-PCR was used to detect mRN As for iN OS (/nlles 2- 6) and 
cNOS (/nlles 8-'12). Photograph represents the 462-bp (iNOS) and 422-bp 
(eNOS) products stained by ethidium bromide. Lnll" 1\11, the 100-bp D A 
ladder; Inll es '1 and 7, positive controls using plasmid cDNA for iNOS and 
cNOS, respectively; Inll es 2 and 8, the negative controls using RNA without 
reverse transcription for iN OS and cNOS; Inlles 3- 6, iN OS products 
obtained from various amounts of RT-cDNA (1. 5, 25 , and 125 ng/ 
reac tion) used in PCR; Inll cs 9 10 '12, cNOS products obtained from various 
amounts ofRT-cDNA (1, 5. 25, and '125 ng/ reaction) used in PCR. 
they are well known to express cNOS and iNOS, respectively 
(Bredt e/ ai, 1991; Knowles e/ ai, 1990). Ca2 -!- -dependent NOS 
activity was detected in the cytosolic extractio ns fi-om both stimu-
late d and unstimulated human derma l fibroblasts, but the Ca2+_ 
independent NOS activity was o nly detected in stimulated cells 
(Table II) . 
Human Dermal Fibroblasts Express mRNAs for Both cNOS 
and iNOS Since both Ca 2 + -dependent and -independent NOS 
activities are observed in human dermal fibrobl as ts , we examined 
the e xpress ion of ml"l...NAs for endo thelial cNOS (Marsden et ai, 
1993) and iNOS (Geller et ai, 1993) in the cells, using R T -PCR. 
Figure 3 shows the e thidium bro mide- sta ined PC R products in an 
agarose gel. Lalles 1 and 7 show amplification of cNOS and iN OS 
u sing cO'Tesponding plasmid cDNAs as te mplates in PCR for 
positive control s. The 422-bp product for endothe lial cNOS and 
the 462-bp pro duct for iNOS are the correct sizes for these 
products as indicated by the DNA ladde r (/alle M). When the total 
cellu lar rlN A w ith o ut reverse transcription was used as templates in 
perl, the ban ds for cNOS and iNOS were not apparent (/alles 2 and 
8). T he intensity of the bands in creased with increasing amounts of 
RT-cDNA (/all es 3-6 fo r cN OS and lalles 9-12 fo r iNOS) . These 
Figure 4. Immunocytochemical detection of eNOS and iNOS pro-
teins in human dernlal fIbroblasts. Stimula ted and unstimulated cells 
were stained with a mouse peroxidase anti-peroxidase procedure to visual-
ize cNOS and iN OS proteins. A- C) T he cNOS imll1unostn ining of the 
unstimulated cells. D-F) The iN OS immunostaining of stimulated ce lls . .-1) 
Lower-power view of eNOS immunosta ining. B) High-power view of 
eNOS immunostaining. - . granules in the cytoplasm of strongly staiued 
cell s. C) Control for eNOS. In the control , the primary antibody \Va 
replaced by non illlmune mouse IgG. D) Low-power view of iNO 
ill1111uno sta ining . T he cell s On 1"11ic roscopc sHdcs 'Vlere stimulated \\tith 
(FN-1' plus LPS , fixed. and sta ined with iN OS antibody. E) High-power 
view of iN OS immllnostaining. -, granu les in the cytoplasm of the 
in tensively sta ined cells. F) Contro l for iNOS il11l11l1nosta ining. T he cells 011 
slid es were treated with I FN-1' plus LPS and subjected to the imJl1u11ostain-
ing, but the primary al1libody was replaced by nonimll1unc mOllse 19G. Scalt 
!inrs; A,D) 8 /J-1l1; B,C,E,F) 2 /J-m. 
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results show that human dermal fibroblasts express mRNAs for 
both cNOS and iNOS. 
Human Dermal Fibroblasts Express Both eNOS and iNOS 
Proteins Under low magnification , almost all of the fibrobla sts 
appeared to be sta ined with the cNOS antibody, although som e 
showed relatively intense staining while the others showed rather 
weak staining (Fig 4A) . Unde r high m agnifica tion , the cytoplasm 
around the nuclei of the cells had stronger staining in the intensely 
stained fibroblasts, but the staining in other cells was scattered 
throughout in the cytoplasm (Fig 4B). As shown in Fig 4C, control 
cell s did not show staining when the primary antibody w as replaced 
with nonimmune mouse IgG. For iN OS, the cells on slides were 
incubated with m edium containing either IFN-y and LPS or PBS 
alone for 24 h, fixed, and stained with the peroxidase anti-
peroxidase procedure . Figure 4D shows that o nly some of the 
IFN-y and LPS-treated cells demonstrated intense staining, w hile 
most showed faint staming. The strongly stained area in th e 
stimulated cells was in the cytoplasm close to the nuclei (Fig 4E) . 
When the primary antibody was replaced with nonimJ11une mouse 
IgG, the stimulated control cells did not show staining (Fig 4F). 
Fibroblast-like Cells in Normal HUlnan Dermis Express 
eNOS After cNOS immunosta inin g, SO J11 e of the fibroblast-like 
cells and blood vesse ls in the dermis a re positive under low 
magnification (Fig SA). Under high mag nification, some of the 
fibroblast-like cells showed stronger staining (Fig SB, arrows). The 
cytopJasm close to the nuclei showed stronger staining in the 
intensely stained cells. Endothelial cells of blood vessel are also 
intensely stained with cNOS antibody (data. not shown) . Figure SC 
and D show that all cells in the dermis are negative after iNOS 
illlJ11unostaining. When the primary antibodies were re placed by 
nonimmune mouse IgG, all the cells in the dermis did not show 
staining (Fig SE,F) . 
DISCUSSION 
T he m ain inte rest and rapid progress in NO research is attributed to 
its dive rsity of physio logical and pathophysiologica l functions and 
its synthesis by a variety of cell types (Nathan, 1992) . Besides its 
vasodilatory effect and intercellular messenger functions, NO is 
well known to play roles in the inflammatory response and 
immunoregulati on (Moncada et ai, 1991.). In this study, we de m-
onstrated that fi brobl asts derived from normal human skin sponta-
neously synthesized NO in culture and this production was en-
hanced by stimulating the cells with hrIFN-y and LPS. Synthesis of 
NO by dermal fibroblasts was charactel-istic of both constitutive 
and inducible responses as described in cultured rat aortic endothe-
liaJ cells (Suschek et ai, 1993), since the cells produced relatively 
low amounts of NO without stimulation and the production was 
significantly increased when stimulatcd with hrlFN-y and LPS. T he 
inducible NO synthesis has been reported in rat lung fibrobl asts 
OOt'ens el ai, 1992) and murine dermal fibroblasts (Wemer-fcl-
mayer el ai, 1990). T he amount of NO produced by human derma l 
fibroblasts appears comparable to that pro duced by rod ent fibro-
blasts Oorens el ai, 1992; Wemer-Felmayer el ai, 1990) . The 
physiological significance of the inducible NO production in 
fibroblasts is unknown, but it has been speculated that it could play 
an important role in regulating the inflammatory response to tis sue 
injury Oorens et ai, 1992). 
Here, w e dem o nstrate that human fibroblasts derived from 
normal skin are capable of constitutively synthesizing NO in 
culture. T he constitutive and inducible production of NO by the 
fibroblasts was further confirmed by subsequ ent exp erim ents show-
ing that the cell Iysates from the fibroblasts have both Caz + _ 
dependent and -independent NOS activities, and that the fibro-
blasts express both cNOS and iNOS ml~As and proteins. T he 
physiological significance of constitutive productio n by human 
fibroblasts is not clear; however, this low level of NO constitutively 
re leased by the fibroblasts could playa role in regulating the blood 
flow in healing wounds, directly influencing the wound healjng 
process. 
T H E JOURNAL OF IN VESTIGATIVE DERMATOLOGY 
To confirm that human fibroblasts, like other types of cells, use 
the L-arginine/NO pathway, w e tcsted the effects of the well-
characterized NOS inhibitor L-NMMA (Rees el ai, 1990). Becau e 
L-NMMA inhibits the NOS activity by competing with the normal 
substrate L-arginine, addition of excess L-arginine should restore 
the production of NO. T h e data show that NO production by 
fibroblasts is indeed inhibited by L-NMMA, and the addition of 
exccss L-arginine but not D-arginine restored it, demonstrating that 
the cells specifically use the L-arginine/NO pathway. These results 
are in agreement with the inhibition of NO synthesis by L-NMMA 
in rat lung fibroblasts OOl'ens e/ ai, 1992) and murine denna1 
fi broblasts (Werner-Felmayer el ai, 1990). T his is not surprising, 
sin ce all types of cells studied in mammals use this pathway in NO 
synthesis. 
The results of the radioactive citrulline assay showed that the ceU 
lysates possessed both Ca2 + -dependent and -independent NOS 
activities, suggesting that human fibroblasts expressed both cNOS 
and iNOS. As expected the Ca 2 + -dcpcndcnt NOS activity was not 
significantly influenced by stimulation with IFN-y and LPS. T he 
Ca2 + -dependent NOS activity in the fibroblasts was lower than 
that in pig endocardial cells (Schulz el ai, 1991) or human umbjJicaJ 
vei.n endothelial cells (Rosenkranz-Weiss el ai, 1994) but was in the 
same range (0.5-5.0 pmollmg protein/ min) . It was of interest that 
the J774A .1 cells also showed Ca2 + -dependcnt NOS activity in the 
sa me range. Ca2 + -dependent NOS activity has not been previously 
reported in these macrophages; however, this finding supported the 
prev io us evidence that human monocytes/m acrophages expressed 
cNOS mRNA (Reiling el ai, 1994). T he leve l ofCa2 + -independent 
NOS activity in the ce ll Iysates was similar to that found in rat 
myoca rdial cells (Schulz el ai, 1992), human B lymphocytes (Man-
nick el ai, 1994) , and human keratinocytes (Heck el ai, 1992), but 
was mu ch lower than that in rat (Griscavage el ai, 1993) or murine 
(Vodovotz e/ ai , 1993) macrophages. 
To confu'm that th e Ca2 +-dependent and -independent NOS 
activities in human dermal fibroblasts are due to cNOS and iNOS, 
wc exa mincd the cNOS and iNOS ml"lNAs in the cells . Because of 
the low levels of NO production and low levels of NOS activities 
in human derm al fibroblasts, we used RT-PCR to detect tile 
mRNAs. T hc sequences of the oligonucleotide primers used in this 
study arc the same as those used in the R T-PCR procedure for 
detection of cNOS and iNOS ml"lNAs in human monocytes/ 
m acrophages (Reiling et ai, 1.994) . The 422- and 462-bp RT-PCR 
pl-odu cts deri ved from hum an monocytes/macrophages showed 
> 99% and 99% identi ty to human endothelial cNOS and human 
h epatocyte iN OS cDNA, respectively (Reiling el ai, 1994). Thus, 
w e believe that the 422- and 462-bp R T -PCR products from 
human dermal fibrobl as ts are identical to human endothelial cNOS 
and human hepatocyte iNOS. Our data indicate that human dermal 
fibroblasts express the mRNAs for both cNOS and iNOS. 
T he final corrobora tion of cNOS and iNOS in human dermaJ 
fibroblasts com es from immunocytochemistry and immunofluores-
cen ce. T he results demonstra te that both stimulated and unstimu-
lated cells ex press cNOS protein, while the stimulated cells express 
more iNOS protein than unstimulated cells. Some unstimulated 
cells also showed faint staining with anti-iNOS antibody. Tlus may 
be duc to low levels of activation of the cells by the culture 
conditions (24 h on slides, not in culture fla sks) and/or a weak 
cross-reaction between the mouse macrophage iNOS antibody and 
human cNOS. Some of the fibroblast-like cells in normal dernus 
are stained with cNOS antibody, suggesting that these cells ma)' 
express cNOS and produce NO ill lIillO, but all the cells in normal 
dennis are negative when stained with iNOS an tibody. Tlus may be 
du e to lack of proper induction of th e enzym e ill nom1al skin. 
The significance of NO production by human dermal fibroblasts 
is not clear. It call be speculated that, in the wound, the constitutive 
low levels of NO produced by fibroblasts, along with the N O 
produced by vascular endothelial cells, maintain a lugher rate of 
blood flow in the wOllnd. The increased blood flow would facilitate 
both nutrition and cell infiltration, which bene fit the wound 
healing process. Furthermore , this low level of NO produced by 
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Figure 5, Fibroblast-like cells in human dermis express cNOS proteins as determined by immunocytochemistry. Par affin-embedded sections 
fro m human skin punch biopsies were stained with a mouse pcro,,;dase anti-peroxidase procedure to visualize cNOS and iNOS proteins. a, b) and e, d) The 
cNOS and iN O S immllnostain ing, respectively. eJ) The nega tive controls, i.n which the primary antibodies were replaced by nonimmune mouse IgG. a) 
Low-power view o f cNOS immullostaining . Som e cells in the dermis and the blood vessels show ed positive sta.ining. b) High-pow er view of cN O S 
immunostaining. Som e of the fibroblast-like cell s in the dermis are stained with eNOS antibody. - , granules in the cytoplasm o f strongly stained 
fib r o blast-likc cell s. c) l ow-power view o f iN O S imI11unostaining . N o positive stained cells in the dermis. High-power view of iN OS immunos taining . All 
tlte fIbroblast- like cell s and o thcr type of cell s axe negati ve . e) Low-pow er view of negative control. J) High-power view of negative co ntrol. All the cells 
in th e dermis arc negative . Scale bil l's: a,e,c) 10 J-1m ; (b ,rlJ) 2. 5 J-1m. 
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fibroblas ts could neutralize the oxygen free radicals released by 
in filtrated le ukocytes, thus protecting celIs fro m d a m age by oJl.'ygen 
and hyd roxyl radicals (H arbrecht c/ ai, 1992). O n th e other hand. 
cytoki nes released by infi ltrated leukocytes and LPS associated w ith 
bacterial invasion co uld stimulate neutro phi ls, Inacrophages , and 
the wound fi broblas ts to produce large am ollnts of N O, which in 
turn migh t inhib.i t the cytokille and N O produ c tion by the infil-
trated leukocytes (Griscavage el ai , 1993) , and redu ce cell prolife r-
ati on (Firnh abel' c/ ai, 1993). T his co uld provide a negative 
regulatio n o f the inflammatory respo nses of th e wound, sin ce 
severe inflammation and high levels of N O can cau se m assive tissu e 
damage detrimental to wound hea ling. Inte resti n.gly, transforming 
growth fa cto r-/3 , known to be a potent fl bl'Ogen ic cytokine that 
enhances wo und healing, has been repo rted to inhibit NO produc-
tion of macroph ages (Vodovotz c/ ai, 1993 ) , suggestin g that high 
levels of N O may inhibit the wo und healing process. 
In con cl usion , hum an derm al fi broblasts sponta neously pl'Oduce 
N O in cul ture, and this productio n is increased upon stimulatio n 
with TFN-')I and LPS. The constituti ve and inducible NO synthesis 
by the ce lls is mediated by Ca2 '
" 
-dependen t and -independent N OS 
ac tivities corresponding to cN OS and iNOS. From these findings, 
we specula te that human dermal fibro blasts m ay b e involved in the 
inflammatory response to skin injm'y and acti vely participate in 
wo und healing and scar ti ssue rem odeling. 
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